Navigation Links
Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting
Date:5/12/2008

YOKNEAM, Israel, May 13 /PRNewswire/ -- Lumenis Inc., a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, and ophthalmic applications, announced today the launch of a Holmium Laser Enucleation of the Prostate (HoLEP) preceptor program that will provide training opportunities for urologists who are interested in learning and performing HoLEP. The abundance of clinical evidence suggests that HoLEP provides superior outcomes in treating Benign Prostatic Hyperplasia (BPH) of all gland sizes(1). For large prostates, HoLEP is a surgical laser procedure that has been shown to be safe and effective(1,2,3). At this year's AUA meeting, there will be a series of speeches, skills labs and roundtable discussions that will feature HoLEP. For details visit http://www.GetPowerSuite.com.

Patients are commonly put on medication as an initial treatment for BPH. The effect of medical therapy is limited and urologists are increasingly seeing patients with larger prostates by the time they are referred for surgery. TURP, transurethral resection of the prostate, has been the standard surgical procedure for the treatment of BPH, however, the body of clinical evidence now shows that HoLEP provides a superior treatment outcome and durability(2).

"I have been a firm believer in HoLEP as it is the most clinically proven laser treatment for BPH," said Dr. Mostafa Elhilali, Chair, Department of Surgery, McGill University. "It is good to see that the company is providing the proper resources to ensure that this procedure is properly adopted by the broader urology community worldwide."

Dr. James Lingeman, Clinical Professor of Urology, Indiana University School of Medicine, stated, "There are many treatment modalities for BPH, however, none have the history of proven clinical outcomes for prostates of any size that HoLEP has. I have trained many phy
'/>"/>

SOURCE Lumenis Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
2. Lumenis Ltd. Announces Senior Leadership Appointments Strengthening the Companys Strategic Businesses
3. Alma Lasers Answers Lumenis Complaint
4. Lumenis(R) Seeks Shareholder Approval of Proposed Class Action Settlement
5. Lumenis Sues Alma Lasers and its 4 founders for 200 Million Shekels
6. Lumenis Announces changes in Lumenis Vision Strategic Business Unit
7. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
8. UPMC Health Plan Launches New Personal Health Record
9. HealthInsuranceFinders.com Launches Video Contest for Young Directors
10. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
11. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...lar cancer who were treated with cisplatin-based c...g neurological side effects and Raynaud-like pheno...apy, according to a new study published online Nov...stitute . , Marianne Brydy, M.D., of the Departm... Bergen, Norway, and colleagues conducted a cross-...
(Date:11/25/2009)...grew out of a collaboration between UCLA engineers...e nearly 10 million Americans who suffer from peri...dening of the arteries, peripheral arterial diseas...h narrowed arteries reduce blood flow to the limbs...lar disease, heart attack and stroke, and its prog...
(Date:11/25/2009)...oo short to draw definite conclusions, experts say...s) -- In diabetic patients with blocked coronary a...omes at one year whether patients undergo bypass s...rchers report. , Bypass surgery has been the st...ry artery disease. However, less invasive approach...
(Date:11/25/2009)...tion and treatment clinics to resume Monday, Nov. ...vember 25, 2009 -- Centegra Health System is conti...e shots at four Centegra Primary Care (CPC) vaccin...s arrived. The clinics are at CPC sites in Huntley...open as follows: ,   From 4:30 to 7:30...
(Date:11/25/2009)...logical symptoms, study finds , , WEDNE...e effects are among the potential problems faced b...e treated with cisplatin-based chemotherapy, a new...rwegian men treated for unilateral testicular canc...-up survey conducted from 1998 to 2002. , The r...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
... British study says that Man's best friend might b...tionally sensitive noses, // dogs can smell odors ...gs of varying breeds and ages were trained over se...m six control group participants and one bladder c...
...vention program designed to educate parents about ...toms of asthma in children // say researchers .M...e children were allergic to at least one indoor en...nately high rate. Researchers designed an inter...
...sillectomy is a common procedure in children , eve...ses with milder symptoms.// A new study suggests t...tonsils and adenoids in children with mild throat ... had the surgery, and half were allocated to watch...
...ers from several international centers combined ef...educing risk factors for disease. They looked at 2..., alcohol use, unsafe water, sanitation and hygien...d the world in 2000 resulted from a combination of...
...y, lung cancer is the leading cause of cancer deat...search shows women // have double the risk of deve...searchers in New York studied nearly 3,000 men and...bability of developing lung cancer. To best determ...
...udy confirms the recommendation by the American He... water-soluble fiber,// is beneficial to your hear...between dietary fiber intake and the reduction of ...disease and cardiovascular disease. The study i...
Other Medicine News:Health News:High Fiber Diet Found To Protect The Heart 2
(Date:11/25/2009)...Newswire/--BioTrendsResearchGroup,Inc.releasedWave...rstinamulti-phasesyndicatedmarketresearchprojecttr...omproductlaunchthroughthefirstsixmonthsofavailabil...tionfrom75uniqueDermatologistsandqualitativeinform...Stelara,obstaclestouse,typicalpatienttypes,product...
(Date:11/25/2009)...ov.25/PRNewswire/--RegadoBiosciences,aprivatelyhel...erswithactivecontrolagents,announcedthatDavidMazzo...fray21stAnnualHealthCareConferenceattheNewYorkPala...ivenat1:10pm(EST)onTuesday,December1andwillinclude...eaddevelopmentprogram,theanticoagulantsystem,REG1....
(Date:11/25/2009)...Nov.25/PRNewswire/--SwissrayInternational,Inc.alea...ystems,announcedtodaythatitsoperationshavebeenacqu...sgrowingSwissray,smedicalimagingbrand.Theacquisiti...scontractsandinventory.After25yearsofsuccessandgro...logicaladvancementswithstableandsteadygrowth. ,...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2Employers Recognize Potential Impact of Employee Health Management on Future Plan Costs 53427 1Employers Recognize Potential Impact of Employee Health Management on Future Plan Costs 53427 2Employers Recognize Potential Impact of Employee Health Management on Future Plan Costs 53427 3John Legend and Gap Join 28PRODUCT 29RED 28TM 29 to Help Eliminate AIDS in Africa with Exclusive 28RED 29ZONE Seating at Madison Square Garden 4807 1John Legend and Gap Join 28PRODUCT 29RED 28TM 29 to Help Eliminate AIDS in Africa with Exclusive 28RED 29ZONE Seating at Madison Square Garden 4807 2John Legend and Gap Join 28PRODUCT 29RED 28TM 29 to Help Eliminate AIDS in Africa with Exclusive 28RED 29ZONE Seating at Madison Square Garden 4807 3Online H1N1 Management 3A FairChoice Helps Schools Respond to Infectious Disease on Campus 4806 1Online H1N1 Management 3A FairChoice Helps Schools Respond to Infectious Disease on Campus 4806 2
...9, 2007 /PRNewswire-FirstCall/ - YM,BioSciences In...,and commercializes differentiated products for pa...sented by investigators from Kinki,University Scho...eting of The Japanese Association for Molecular Ta...nstrated the increased,radiosensitivity of human N...
...INESS WIRE)--July 9, 2007 - NexMed, Inc.,(NASDAQ: ...ments,based on the NexACT(R) drug delivery technol...ompleted patient enrollment for Phase,III clinical...homycosis (nail fungus). Pursuant to the terms of ... be entitled to a milestone,payment early next yea...
Other Medicine Technology:YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 2YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 3YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 4NexMed Announces Completion of Patient Enrollment in Two Pivotal,Phase 3 Studies for Anti-Fungal Product 2
Ovation BioNatural Pipette, one-stroke, fixed volume, 200L
Finnpipette Fixed Volume, 200ul
Pipetman F100
Eppendorf Research Series 2100 Fixed-volume Pipette, 100 l
Medicine Products: